Hsa_circRNA_007630 knockdown delays colon cancer progression by modulation of ferroptosis via miR‐506‐3p/AURKA axis

Abstract

AbstractColon cancer contributes to high mortality rates internationally that has seriously endangered human health. Aurora kinase A (AURKA) served as a key molecule in colon cancer. However, its role of AURKA on regulating ferroptosis in colon cancer and their possible interactions with miRNAs and circRNAs remain still elusive. Comprehensive bioinformatics analysis after RNA‐sequencing was conducted to determine the differentially expressed genes (DEGs), ferroptosis‐related DEGs and hub genes. The direct relationship between miR‐506‐3p and hsa_circRNA_007630 or AURKA was predicted, then verified by dual luciferase reporter and quantitative real‐time polymerase chain reaction. The rescue experiments were conducted by cotransfection with si‐hsa_circRNA_007630, miR‐506‐3p inhibitor or pcDNA‐AURKA in HT29 cells. Erastin was used to induce ferroptosis in HT29 cells and validated by detecting levels of intracellular Fe2+, lipid reactive oxygen species, glutathione, malondialdehyde and ferroptosis markers expression. We screened a total of 331 DEGs, 26 ferroptosis‐related genes, among which 3 hub genes were identified through PPI network analysis. Therein, AURKA expression was elevated in colon cancer cells. Moreover, AURKA was targeted by miR‐506‐3p, and hsa_circRNA_007630 operated as miR‐506‐3p sponge. The effect of hsa_circRNA_007630 depletion on the inhibiting malignant phenotypes of HT29 cells was rescued by inhibition of miR‐506‐3p or AURKA overexpression. Additionally, AURKA reduced erastin‐induced ferroptosis in HT29 cells. Depletion of circRNA_007630 exerts as a suppressive role in colon cancer through a novel miR‐506‐3p/AURKA pathway related to ferroptosis, and might become a novel marker for colon cancer.